Potensi Regulasi miR-125a-5p terhadap Ekspresi BCL2 Pasien Kanker Payudara HR+/HER2-
Putri Rohmatul Laili, Prof. dr. Sofia Mubarika Haryana, M.Med.Sc, Ph.D.; Dr.rer.nat. dr. Dyah Laksmi Dewi M.Sc., Sp.B. Subsp. Onk(K)
2026 | Tesis | S2 Bioteknologi
HR+/HER2- breast cancer is the most prevalent breast cancer subtipe and is characterized by complex molecular features. One mechanism involved in its molecular regulation is post-transcriptional regulation by microRNA (miRNA). miR-125a-5p has potential as tumor-suppressor activity, whereas BCL2 is an anti-apoptotic gene that promotes cancer cell survival. This study aimed to analyse miR-125a-5p and BCL2 mRNA expression in patients with HR+/HER2- breast cancer, assess the correlation between them, and evaluate their expression patterns according to molecular subtype and clinicopathological characteristics.
This analytical observational cross-sectional study used plasma samples to measure miR-125a-5p expression and formalin-fixed paraffin-embedded (FFPE) tissue samples to measure BCL2 expression. Expression levels were quantified using RT-qPCR, with cel-miR-39-3p and GAPDH as internal controls for miR-125a-5p and BCL2, respectively. ?CT values were statistically analysed to compare miR-125a-5p and BCL2 expression of patient and control groups, assess the correlation between them, an evaluate their associations with patient’s molecular subtype and clinicopathological status, using p<0>
miR-125a-5p expression was significantly downregulated in patients compared with controls (p=0.0102), while BCL2 expression did not differ significantly (p=0.2818). No significant overall correlation was observed (p=0.8170), although a significant negative correlation emerged in the inverse-expression subgroup p=0.0206). Furthermore, miR-125a-5p tended to decrease (p=0.0053), while BCL2 increased (p=0.0205) with increasing primary tumor size. These findings suggest their potential involvement in tumor progression, although the relation tends to be complex and context-dependent and requires functional validation.
Kata Kunci : regulasi gen pasca-transkripsi, tumor suppressor miR, miR-125a-5p, BCL2, kanker payudara HR+/HER2-